Jiangsu Wuzhong Pharmaceutical Development Co.,Ltd. Posted 78.2 Million Yuan Net Loss in 2022
Listen to the full version

Jiangsu Wuzhong Pharmaceutical Development Co.,Ltd. (江苏吴中医药发展股份有限公司) (600200.SH) reported a net loss of 78.2 million yuan in 2022, reversing a net profit of 20.6 million yuan for the previous year.
Meanwhile, the company posted 2 billion yuan in revenue, up 14.1% year-on-year.
At the end of the reporting period, it had 3.9 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 53.4%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR